Deon B. Doxie

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial”.

Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial

Nature Cancer(2024)10.1038/s43018-024-00818-w

N/A

0.727DataRank · unranked

20 citations

Alexander M. Lesokhin, Barry Paul, Jonathan L. Kaufman, Matthew J. Pianko, Noa Biran +9 more

Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0173

N/A

0DataRank · unranked

33 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

(2023)10.1158/2643-3230.c.6551220

N/A

0DataRank · unranked

0 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Engineering Improved CAR T Cell Products with A Multi‐Cytokine Particle Platform for Hematologic and Solid Tumors

Advanced Healthcare Materials(2024)10.1002/adhm.202302425

N/A

0DataRank · unranked

6 citations

Biaggio Uricoli, Ruby Freeman, AKM Nawshad Hossian, Zhulin He, Ji Young L. Anderson +11 more

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial

OncoImmunology(2025)10.1080/2162402x.2025.2475620

N/A

0DataRank · unranked

13 citations

Olatunji B. Alese, Natalie K. Horvat, Emily R. Greene, Olumide B. Gbolahan, Kathleen Coleman +11 more

High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-1697

N/A

0DataRank · unranked

4 citations

Natalie K. Horvat, Deon B. Doxie, Vaunita C Parihar, Jayden Kim, Cameron J. Herting +15 more

High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.18.649381

N/A

0DataRank · unranked

0 citations

Natalie K. Horvat, Deon B. Doxie, Vaunita Parihar, Jayden Kim, Cameron J. Herting +15 more

HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior

Scientific Reports(2021)10.1038/s41598-021-93807-3

N/A

0DataRank · unranked

29 citations

Yong Zou, Tatiana Novitskaya, Georgii Vasiukov, Aneri Balar, Dianna J. Rowe +9 more

A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

Cancer Letters(2025)10.1016/j.canlet.2025.218233

N/A

0DataRank · unranked

0 citations

Maria Diab, Maggie J. Phillips, Ashley A. McCook‐Veal, Erin E. Grundy, Olatunji B. Alese +12 more